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To assess if (1→3)-β-D-glucan, a microbial cell wall agent normally present in pollen, has the ability to produce pollenlike response,
sensitive persons received a nasal deposition of two doses of (1→3)-β-D-glucan. The percentage of eosinophils and amount of
eotaxin were measured in nasal lavage 30 minutes and 24 hours after challenge. No eﬀect could be demonstrated. The absence of an
inﬂammatory response after (1→3)-β-D-glucan application conﬁrms earlier ﬁndings in inhalation studies.
INTRODUCTION
Microbial cell wall agents (MCWAS) play an impor-
tant role in the development of nonallergic airways in-
ﬂammation in occupational and general environments
with microbial contamination. Gram-negative bacteria
contain a lipopolysaccharide ((LPS), endotoxin) com-
pound on their outer cell surface and dose-response re-
lationships have been found between endotoxin in or-
ganic dusts and respiratory symptoms [1]. In fungi, the
cell wall contains a particular polyglucose agent—(1→3)-
β-D-glucan—that has been found to activate neutrophils
in vitro with a subsequent secretion of inﬂammatory cy-
tokines [2, 3]. In inhalation challenges in animals, there is
an invasion of eosinophils into the airways but the classic
neutrophil response is not present except if water-soluble
compounds are used [4].
Apart from the fungi case, (1→3)-β-D-glucan is also
p r e s e n ti np o l l e n[ 5]. Hypothetically this agent could thus
be responsible for or contribute to the inﬂammation in
the nasal mucosa, caused by inhalation of pollen among
sensitised persons. To evaluate this hypothesis experi-
ments were undertaken where persons with a known hy-
perreactivity to pollen were exposed to pure (1→3)-β-D-
glucan using a nasal spray. The proportion of eosinophils
and amount of eotaxin were determined in nasal lavage
( N A L )ﬂ u i d3 0m i n u t e sa n d2 4h o u r sa f t e re x p o s u r e .
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MATERIALS AND METHODS
Testpersons
Test persons (n = 11) were recruited by advertising
among university students. Inclusion criteria were known
reactivitytopollen,ageof18–35years,neversmokingand
without any current disease or regular medication. The
study was approved by the Ethical Committee.
Glucanexposure
A puriﬁed preparation of (1→3)-β-D-glucan from
Candida albicans was used [6]. A 5-mg aliquot was sus-
pended in 5mL of 0.3N NaOH, ultrasonicated for 30
minutes, and diluted in phosphate buﬀered saline (PBS)
till a concentration of 5000 and 500ng/mL. Each of these
doses was further diluted in PBS and 200µL was in-
serted in a Biodose nasal applicator (Valois, France) that
produced an aerosol of 100µL for each of the two ac-
tuations. The resulting doses of 50 and 5ng were cho-
sen based upon the data on the amount of (1→3)-β-
D-glucan in pollen where a typical spring exposure of
5000pollen/m3 was calculated to correspond to 5ng
(1→3)-β-D-glucan/m3 [5]. Control applications con-
tained PBS only. The subjects were exposed in both nos-
trils on three occasions, at least one week apart, randomly
tothehighandlowdosesandcontrolﬂuid.Theexposures
took place during the month of March.
Nasallavage
The subjects underwent NAL 30 minutes prior to
exposure (baseline) and 30 minutes and 24 hours af-
terwards. NAL was performed according to a method
previously described [7]. A syringe with 6mL PBS was
connected to a nasal olive and inserted in one nostril. The
ﬂuid was slowly injected and withdrawn; this process was
repeated ﬁve times. The same procedure was repeated in2005:1 (2005) Pollen Allergy and Glucan 51
the other nostril using the same ﬂuid. The collected ﬂuid
was stored in plastic tubes in ice until centrifugation of
200g for 10 minutes. The supernatant was removed and
stored frozen at −70◦C. The cell pellet was resuspended in
PBS and a cell smear was prepared.
Cellcounts
AcytosinecellsmearpreparationoftheNALﬂuidwas
stained with May-Gr¨ unewald-Giemsa and 200 cells were
countedinanopticalmicroscopeat1000×magniﬁcation,
determining the proportion of eosinophils.
Eotaxinanalysis
The amount of eotaxin in the NAL was analysed us-
ing an ELISA commercial preparation (Quantikine Hu-
manEotaxin/CCL11,R&DSystems,Abigdon,Oxon,UK)
with a sensitivity of 5pg/mL.
RESULTS
A very large proportion of eosinophils was found
among two subjects in the control tests (80% and 25.5%)
as compared to the average of the group which was
1.6. None of these persons showed an increase in the
proportion of eosinophils after application of (1→3)-β-
D-glucan. Table 1 shows the proportion of eosinophils




Table 1. Eosinophils in nasal lavage (percentage of total cells
counted). Mean values and ranges in parentheses (excluding 2
persons with high baseline values, see the text).
Exposure Before 30min 24h
Control exposure 1.65 (0–9.5) 1.1( 0 – 4 .0) 3.2 (0–24)
Glucan (low dose) 0.7( 0 – 4 .0) 0.5( 0 – 2 .3) 0.8( 0 – 3 .3)
Glucan (high dose) 0.8( 0 – 2 .0) 0.9( 0 – 3 .4) 1.6( 0 – 9 .1)
Figure 1 shows the amount of eotaxin in the NAL
ﬂuid. The distribution of values was the same, irrespec-























































Figure 1. The amount of eotaxin in nasal lavage after the appli-
cation of (1→3)-β-D-glucan (G) or PBS (C).
DISCUSSION
The present study is of an exploratory nature and the
number of subjects small. The dose in the nose was calcu-
lated basing the exposure on a typical spring exposure of
5000pollen/m3 which means that the doses of (1→3)-β-
D-glucan used were well in the range of the normal envi-
r o n m e n t a ld o s e[ 5].
The absence of an inﬂammatory reaction after ex-
posure to (1→3)-β-D-glucan agrees with results from
inhalation studies in animals [8, 9, 10]. On the other
hand, a marked nasal swelling and increased amounts of
interleukin-8 were found in a study where subjects in-
haled ﬂoor dust, spiked with (1→3)-β-D-glucan (Kjaer-
gaard, personal communication). Whether this diﬀerence
reﬂects the presence of particles in the ﬂoor dust or a
higher dose level is not clear.
In summary, the results do not support the hypothe-
sis that (1→3)-β-D-glucan induces the inﬂammatory re-
sponse seen after exposure to pollen in sensitised subjects.
ACKNOWLEDGMENTS
This project was supported by funds from Wilhelm
and Martina Lundgrens Research Foundation. Edward
Erin and Trevor Hansel at the Royal Brompton Hospital
kindly oﬀered advice regarding the design of the study.
Pierre Michelet at Valois, France, kindly supplied the ex-
pertise and equipment for the Biodose. The technical as-
sistance from Gunilla Arvidsson is greatly appreciated.
REFERENCES
[1] Rylander R. Endotoxin in the environment—
exposureandeﬀects.JEndoto xinRes.2002;8(4):241–
252.
[2] Ohno N, Egawa Y, Hashimoto T, Adachi Y, Yadomae
T. Eﬀect of beta-glucans on the nitric oxide synthesis
by peritoneal macrophage in mice. Biol Pharm Bull.
1996;19(4):608–612.
[3] Adachi Y, Okazaki M, Ohno N, Yadomae T. En-
hancement of cytokine production by macrophages
stimulatedwith(1→3)-β-D-glucan,grifolan(GRN),
isolated from Grifola frondosa. Biol Pharm Bull.
1994;17(12):1554–1560.
[4] Fogelmark B, Thorn J, Rylander R. Inhalation of
(1→3)-β-D-glucan causes airway eosinophilia. Me-
diators Inﬂamm. 2001;10(1):13–19.
[ 5 ]R y l a n d e rR ,F o g e l m a r kB ,M c W i l l i a mA ,C u r r i eA .
(1→3)-β-D-glucan may contribute to pollen sensi-
tivity. Clin Exp Immunol. 1999;115(3):383–384.
[6] Ishibashi K, Miura NN, Adachi Y, et al. Relationship
between the physical properties of Candida albicans
cell well β-glucan and activation of leukocytes in
vitro. Int Immunopharmacol. 2002;2(8):1109–1122.
[7] Wihl JA, Baumgarten CR, Petersson G. Contralat-
eral diﬀerences among biomarkers determined by a52 L. Beijer and R. Rylander 2005:1 (2005)
modiﬁed nasallavagetechniqueafterunilateralanti-
gen challenge. Allergy. 1995;50(4):308–315.
[8] Fogelmark B, Sjostrand M, Rylander R. Pulmonary
inﬂammation induced by repeated inhalations of
β-(1,3)-D-glucan and endotoxin. Int J Exp Pathol.
1994;75(2):85–90.
[9] Wan GH, Li CS, Guo SP, Rylander R, Lin RH. An
airborne mold-derived product, (1→3)-β-D-glucan,
potentiates airway allergic responses. E u rJI m m u n o l .
1999;29(8):2491–2497.
[10] Tho rnJ ,Beije rL,R yland e rR.Eﬀectsafterinhalation
of (1→3)-β-D-glucan in healthy humans. Mediators
Inﬂamm. 2001;10(4):173–178.